📰 Clinical Sciences News
Page 16 - Clinical Sciences News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Clinical Sciences. Real-time updates on events, politics, business and more.
August 25, 2023
The UNILAG VC, Folasade Ogunsola, said the team’s impact on the GP2 further accentuates the university’s fast migration into a future-ready institution with imprints in various fields, including science.
August 24, 2023
National Agency For Food And Drug Administration And Control (NAFDAC), has certified the use of GLUCOZIL for the treatment of diabetes mellitus.
August 24, 2023
NAFDAC made this known in a statement by its Head of Corporate Communication, Mike Aladenika, on Thursday.
August 24, 2023
The Ambrose Alli University (AAU), Ekpoma, received the approval of NAFDAC, for its GLOCOZIL medicine for the treatment of diabetes.
August 22, 2023
22.08.2023 - Professor Patrick Chinnery, Head of the Department of Clinical Neurosciences at the University of Cambridge, has been appointed as the new Executive Chair of the Medical Research Council (MRC), it was announced today.
August 18, 2023
Researchers found that being fit between the ages of 16 and 25 was associated with lower risks of certain types of cancer, particularly ones that affect the GI tract.
August 16, 2023
The ‘impact of regular use of moisturizer to mitigate skin aging’ and ‘longevity proteins play a key role in promoting youthful skin properties’ were just two of the subjects presented by Estée Lauder during this year’s poster presentation.
August 16, 2023
Researchers followed over a million Swedish men over 30 years and found those with good cardiorespiratory fitness levels at the start were up to two-fifths less likely to develop the cancers
August 16, 2023
WEDNESDAY, Aug. 16, 2023 (HealthDay News) -- Having good fitness while young can really pay off when it comes to cancer risk later in life.
August 15, 2023
Study examined whether other solutions might create less lung inflammation. The findings supported the continued use of saline.